
Tim Farries
CMC Regulatory
Career Highlights
Tim Farries brings exceptional expertise in CMC (Chemistry, Manufacturing, and Controls) regulatory and development aspects of cell and gene therapies to Cell One Partners. As an associate, he specializes in viral vectors, genome editing, stem cell, RNA-based, and CAR-T products. With over 10 years of consulting experience, including roles as Principal Consultant at Biopharma Excellence and Chief Scientific Officer at ERA Consulting, Tim has led teams that achieved groundbreaking regulatory approvals for products utilizing stem cells and genome editing. His deep understanding of regulatory landscapes and his ability to navigate complex approval processes make him an invaluable asset to the team.
In addition to his consulting experience, Tim has spent more than 20 years in the commercial development of cutting-edge therapeutics. His career includes significant roles at companies of various sizes, from small enterprises like Ark Therapeutics to medium-sized firms such as Sangamo Biosciences, and large developers like Novartis. This diverse background has equipped him with a comprehensive understanding of the industry, enabling him to effectively manage the development and regulatory aspects of advanced therapies. Tim's extensive experience and leadership in CMC regulatory affairs ensure that Cell One Partners remains at the forefront of innovation and compliance in the cell and gene therapy sector.
Education
Prior to this he had obtained his degree in Biochemistry from the University of Oxford, and a Ph.D. from the Universities of Cambridge, and followed these with productive academic research at Washington University in St. Louis and MRC laboratories in the UK.